Low-risk papillary thyroid cancer: times are changing

Area of Science:

• Oncology
• Endocrinology
• Medical Guidelines

Background:

• Increasing prevalence of papillary thyroid cancer (PTC), particularly low-risk PTC (MACIS <6).
• Widespread use of advanced neck imaging and diagnostic techniques contributing to increased PTC detection.
• Current management paradigms for PTC are based on studies from the 1970s and 1980s, potentially leading to overtreatment.

Purpose of the Study:

• To evaluate the current management of papillary thyroid cancer (PTC) in light of rising prevalence.
• To assess the appropriateness of established treatment and follow-up protocols for low-risk PTC.
• To advocate for revised guidelines that differentiate management strategies for various thyroid cancer subtypes.

Main Methods:

• Analysis of observational cohort studies from the last two decades.
• Review of current treatment standards including total thyroidectomy and central neck dissection.
• Assessment of follow-up tools such as suppressed basal thyroglobulin and neck ultrasound.

Main Results:

• Low-risk PTC appears to be overtreated under current guidelines.
• Established follow-up methods like radioiodine ablation, body scans, and stimulated thyroglobulin are obsolete for most low-risk PTC cases.
• Total thyroidectomy and central neck dissection are standard, with suppressed thyroglobulin and annual ultrasound as key follow-up tools.

Conclusions:

• Future differentiated thyroid cancer guidelines must distinguish between low-risk PTC, high-risk PTC, and follicular cancer.
• Current management for low-risk PTC may involve unnecessary interventions.
• Evidence suggests a need for updated, risk-stratified management protocols for thyroid cancer.